188
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Contrast Sensitivity Testing in Age-Related Macular Degeneration Using Motion Diamond Stimulus

, , , ORCID Icon, , , ORCID Icon, & show all
Pages 507-515 | Published online: 25 Feb 2022

References

  • Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–e116. doi:10.1016/S2214-109X(13)70145-1
  • Mitchell J, Bradley C. Quality of life in age-related macular degeneration: a review of the literature. Health Qual Life Out. 2006;4:97. doi:10.1186/1477-7525-4-97
  • Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358(24):2606–2617. doi:10.1056/NEJMra0801537
  • Gillies MC, Hunyor AP, Arnold JJ, et al. Effect of ranibizumab and aflibercept on best-corrected visual acuity in treat-and-extend for neovascular age-related macular degeneration: a randomized clinical trial. JAMA Ophthalmol. 2019;137(4):372–379. doi:10.1001/jamaophthalmol.2018.6776
  • Boyer DS, Antoszyk AN, Awh CC, et al. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007;114(2):246–252. doi:10.1016/j.ophtha.2006.10.045
  • Wu Z, Ayton LN, Luu CD, Guymer RH. Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration. JAMA Ophthalmol. 2015;133(4):442–448. doi:10.1001/jamaophthalmol.2014.5963
  • Ross C, Stelmack JA, Stelmack TR, Fraim ME. Preliminary examination of the reliability and relationship to clinical state of a measure of low vision patient functional status. Optom Vis Sci. 1990;68:918–923. doi:10.1097/00006324-199112000-00002
  • McGuinness MB, Finger RP, Wu Z, et al. Properties of the impact of vision impairment and night vision questionnaires among people with intermediate age-related macular degeneration. Transl Vis Sci Technol. 2019;8(5):3. doi:10.1167/tvst.8.5.3
  • Owsley C, McGWIN GE, Sloane ME, Stalvey BT, Wells J. Timed instrumental activities of daily living tasks: relationship to visual function in older adults. Optom Vis Sci. 2001;78(5):350–359. doi:10.1097/00006324-200105000-00019
  • Dorr M, Elze T, Wang H, Lu ZL, Bex PJ, Lesmes LA. New precision metrics for contrast sensitivity testing. IEEE J Biomed Health. 2017;22(3):919–925. doi:10.1109/JBHI.2017.2708745
  • Alexander MF, Maguire MG, Lietman TM, Snyder JR, Elman MJ, Fine SL. Assessment of visual function in patients with age-related macular degeneration and low visual acuity. Arch Ophthalmol. 1988;106:1543–1547. doi:10.1001/archopht.1988.01060140711040
  • McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol. 2000;84(3):244–250. doi:10.1136/bjo.84.3.244
  • Scott IU, Feuer WJ, Jacko JA. Impact of visual function on computer task accuracy and reaction time in a cohort of patients with age-related macular degeneration. Am J Ophthalmol. 2002;133(3):350–357. doi:10.1016/S0002-9394(01)01406-4
  • Roh M, Selivanova A, Shin HJ, Miller JW, Jackson ML. Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration. PLoS One. 2018;13(5):e0196481. doi:10.1371/journal.pone.0196481
  • Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci. 1988;2:187–199.
  • Arditi A. Improving the design of the letter contrast sensitivity test. Investig Ophthalmol Vis Sci. 2005;46(6):2225–2229. doi:10.1167/iovs.04-1198
  • Flynn OJ, Shapiro AG. The perpetual diamond: contrast reversals along thin edges create the appearance of motion in objects. I-Perception. 2018;9(6):2041669518815708.
  • Mishra S, Maganti N, Squires N, et al. Contrast sensitivity testing in retinal vein occlusion using a novel stimulus. Transl Vis Sci Technol. 2020;9(11):29. doi:10.1167/tvst.9.11.29
  • Mangione CM. NEI VFQ-25 Scoring Algorithm. Rockville, MD: National Eye Institute; 2000.
  • Özdek ŞC, Erdinç MA, Gürelik G, Aydin B, Bahçeci U, Hasanreisoglu B. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings. Ophthalmologica. 2005;219(2):86–92. doi:10.1159/000083266
  • Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 2007;144(4):627–637. doi:10.1016/j.ajo.2007.06.039
  • Demb JB. Functional circuitry of visual adaptation in the retina. J Physiol. 2008;586(18):4377–4484. doi:10.1113/jphysiol.2008.156638
  • Porciatti V, Bosse B, Parekh PK, Shif OA, Feuer WJ, Ventura LM. Adaptation of the steady-state PERG in early glaucoma. J Glaucoma. 2014;23(8):494. doi:10.1097/IJG.0b013e318285fd95
  • Tebartz van Elst L, Greenlee MW, Foley JM, Luecking CH. Contrast detection, discrimination and adaptation in patients with Parkinson’s disease and multiple system atrophy. Brain. 1997;120(12):2219–2228. doi:10.1093/brain/120.12.2219
  • Bansback N, Czoski-Murray C, Carlton J, et al. Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity. Qual Life Res. 2007;16(3):533–543. doi:10.1007/s11136-006-9126-8